Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$38.93

0.83 (2.18%)

10:29
11/25/16
11/25
10:29
11/25/16
10:29

GlaxoSmithKline announces EU regulatory submission for shingles vaccine

GlaxoSmithKline announced the regulatory submission of a Marketing Authorisation Application to the European Medicines Agency seeking approval for its candidate shingles vaccine, Shingrix, for the prevention of herpes zoster in people aged 50 years or over. The candidate vaccine is a non-live, recombinant vaccine to help prevent shingles and its complications. The phase III clinical trial programme showed that by reducing the incidence of shingles, the candidate vaccine also reduced the overall incidence of postherpetic neuralgia, a form of chronic pain associated with shingles. Regulatory approval is being sought for the vaccine to be given intramuscularly in two doses, with a two-to-six month interval between doses. The regulatory submission for the candidate vaccine is based on a comprehensive phase III clinical trial programme evaluating its efficacy, safety and immunogenicity in more than 37,000 people. This includes the ZOE-50 and ZOE-70 studies published in the New England Journal of Medicine in April 2015 and September 2016, respectively. The submission to the EMA follows regulatory submissions to the U.S. FDA in October of this year and to Canada regulatory authorities earlier this month, with a Japan submission planned for 2017.

  • 29

    Nov

GSK GlaxoSmithKline
$38.93

0.83 (2.18%)

09/23/16
09/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Brian Nowak initiated Activision Blizzard (ATVI) and Electronic Arts (EA), both with Overweight ratings. The analyst is bullish on the digital gaming shift away from "units sold" to a business model based on users, engagement, and digital monetization. He sees digital in-game offerings resulting in recurring and growth user bases, increased per-game engagement, and further monetization opportunities. 2. AstraZeneca (AZN) and GlaxoSmithKline (GSK) both initiated with Overweight ratings by Piper Jaffray analyst Richard Purkiss. 3. Achillion (ACHN) initiated with an Outperform by Wedbush analyst Heather Behanna, who set a $13 price target on the shares. 4. Sysco (SYY) initiated with an Underweight at Barclays and $48 price target by analyst Karen Short. 5. Five Below (FIVE), Dollar Tree (DLTR) and Dollar General (DG) all initiated with Equal Weight ratings by Barclays analyst Karen Short. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $95
RBCM
Outperform
Gilead HIV franchise could see risk from competitor data, says RBC Capital
RBC Capital analyst Michael Yee said his conversations with doctors leads him to think two dolutegravir HIV "doublet" studies being conducted by GlaxoSmithKline (GSK) and ViiV Healthcare - Glaxo's joint venture with Pfizer (PFE) and Shionogi - are likely to work and present an underappreciated risk to Gilead's (GILD) HIV franchise. Talks with investors lead Yee to believe few are even aware of this risk and that the consensus view is underestimating the probability these non-inferiority trials will work. Arguing that the consensus view should factor in more conservative assumptions for Gilead's HIV business post 2018 due to this risk, Yee cut his price target on Gilead to $95 from $105, but keeps an Outperform rating on the shares.
10/06/16
PIPR
10/06/16
NO CHANGE
Target $46
PIPR
Overweight
Piper thinks Alnylam failure is positive for Ionis
Piper Jaffay analyst Joshua Schimmer thinks Alnylam Pharmaceuticals' (ALNY) "abrupt halt" of revusiran for TTR cardiomyopathy is likely a positive for Ionis Pharmaceuticals' (IONS) transthyretin program. The move "knocks out a competitive drug" while Ionis and GlaxoSmithKline (GSK) remain on their previously indicated timeline, Schimmer tells investors in a research note. The analyst at this point believes Alnylam's setback will be limited to revusiran and not read-through to other Gal-Nac programs or other TTR cardiomyopathy or polyneuropathy programs. He keeps an Overweight rating on Ionis with a $46 price target,
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.

TODAY'S FREE FLY STORIES

FMSA

Fairmount Santrol

$9.27

-0.08 (-0.86%)

17:06
12/07/16
12/07
17:06
12/07/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Fairmount Santrol »

Point72 Asset reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

COVS

Covisint

$2.30

0.1 (4.55%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Covisint signs agreements with SAIC General Motors, NextEV »

Covisint Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$770.19

5.47 (0.72%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Amazon launches menswear brand 'Buttoned Down' »

Amazon announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$32.65

-1.15 (-3.40%)

16:50
12/07/16
12/07
16:50
12/07/16
16:50
Hot Stocks
Breaking Hot Stocks news story on AMC Entertainment »

Monterey Capital III…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCFT

MCBC Holdings

$14.18

0.23 (1.65%)

16:43
12/07/16
12/07
16:43
12/07/16
16:43
Syndicate
MCBC Holdings files to sell 1M shares of common stock for holders »

B. Riley and Co. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.97

-0.03 (-0.17%)

16:42
12/07/16
12/07
16:42
12/07/16
16:42
Syndicate
Eagle Point Credit files to sell 1.15M shares of common stock »

Keefe, Bruyette &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:39
12/07/16
12/07
16:39
12/07/16
16:39
General news
Moody's changes outlook on Italy to negative from stable »

Moody's Investors…

DNB

Dun & Bradstreet

$123.83

2.42 (1.99%)

16:39
12/07/16
12/07
16:39
12/07/16
16:39
Hot Stocks
Dun & Bradstreet appoints CEO Robert Carrigan as chairman »

Dun & Bradstreet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIND

Mitcham Industries

$3.73

0.04 (1.08%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Earnings
Mitcham Industries reports Q3 EPS (62c), consensus (43c) »

Reports Q3 revenue $8.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$13.30

0.09 (0.68%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Hot Stocks
Crescent Point Energy announces $1.45B CapEx budget for 2017 »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$24.58

0.59 (2.46%)

16:34
12/07/16
12/07
16:34
12/07/16
16:34
Hot Stocks
Corning announces $4B share repurchase program »

Corning announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTT

Wireless Telecom Group Inc

$1.58

0.01 (0.64%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Wireless Telecom Group Inc appoints Michael Kandell as CFO »

Wireless Telecom Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$4.85

0.1 (2.11%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Argos announces rocapuldencel-T as generic name for AGS-003 »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WWE

WWE

$19.43

0.48 (2.53%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
WWE co-founder says appointed by Trump to lead Small Business Administration »

Linda McMahon, WWE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPC

W.P. Carey

$59.52

1.08 (1.85%)

16:31
12/07/16
12/07
16:31
12/07/16
16:31
Hot Stocks
W.P. Carey raises quarterly dividend to 99c per share »

W.P. Carey reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CM

CIBC

$83.70

1.28 (1.55%)

, PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Conference/Events
PrivateBancorp to host special shareholder meeting »

Special Shareholder…

CM

CIBC

$83.70

1.28 (1.55%)

PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Options
Preliminary option volume of 21.5M today »

Preliminary option volume…

CMTL

Comtech

$12.75

0.77 (6.43%)

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Comtech declares 10c quarterly dividend, sees FY17 quarterly dividends unchanged »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

SKLN

Skyline Medical

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Nations Advisory Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

River North Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Kodiak Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$21.15

-0.02 (-0.09%)

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Conference/Events
William Blair software/SaaS analyst holds a tech roundtable dinner meeting »

Software/SaaS Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

TYL

Tyler Technologies

$147.73

1.54 (1.05%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Hot Stocks
Tyler Technologies rejects media reports of issues with Odyssey product »

Tyler Technologies issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

HRB

H&R Block

$23.34

0.65 (2.86%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Earnings
H&R Block reports Q2 continuing ops EPS (67c), consensus (68c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TSN

Tyson Foods

$58.82

1.43 (2.49%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Hot Stocks
Tyson incoming CEO Tom Hayes sees growth in retail, foodservice businesses »

Tyson Foods president and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.